Neuroone Medical Technologies (NMTC) Cash from Operations (2010 - 2026)

Neuroone Medical Technologies has disclosed Cash from Operations across 17 years of filings, most recently posting 1328711.0 for Q1 2026.

• Quarterly Cash from Operations fell 2266.61% year-over-year to 1328711.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7433723.0 (down 52.47% YoY) and the FY2025 annual result came in at 2837272.0, up 74.23% from the prior year.
• Cash from Operations climbed to 1328711.0 in Q1 2026, from 3115835.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 1017817.0 in Q3 2022 and bottomed at 3809391.0 in Q4 2023.
• The 5-year median for Cash from Operations is 2636624.0 (2022), against an average of 2118878.24.
• Year-over-year, Cash from Operations jumped 150.16% in 2022 and sank 2266.61% in 2026.
• Neuroone Medical Technologies' Cash from Operations stood at 3492253.0 in 2022, then dropped by 9.08% to 3809391.0 in 2023, then jumped by 105.46% to 208049.0 in 2024, then tumbled by 1597.64% to 3115835.0 in 2025, then soared by 57.36% to 1328711.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 1328711.0, 3115835.0, and 1525672.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.